Challenges in Designing HIV Env Immunogens for Developing a Vaccine - Structure-Based Study of Viral Replication - page 376

148. Buckner C, Gines LG, Saunders CJ, et al . (2004) Priming B cell-medi-
ated anti-HIV envelope responses by vaccination allows for the long-
term control of infection in macaques exposed to a R5-tropic SHIV.
Virology 320 : 167-180.
149. Quinnan GV, Jr., Yu XF, Lewis MG, et al . (2005) Protection of rhesus
monkeys against infection with minimally pathogenic simian-human
immunodeficiency virus: correlations with neutralizing antibodies and
cytotoxic T cells. J Virol 79 : 3358-3369.
150. Lian Y, Srivastava I, Gomez-Roman VR, et al . (2005) Evaluation of
envelope vaccines derived from the South African subtype C human
immunodeficiency virus type 1 TV1 strain. J Virol 79 : 13338-13349.
151. Myszka DG, Sweet RW, Hensley P, et al . (2000) Energetics of the
HIV gp120-CD4 binding reaction. Proc Natl Acad Sci USA 97 :
9026-9031.
152. Pal AK, Rahman S, Chatterjee SN. (1993) Electron microscopic
study of phages and aberrant structures produced by induction of
prophage kappa in Vibrio cholerae el tor cells. Indian J Exp Biol 31 :
955-962.
153. Gershoni J, Denisova G, Raviv D, et al . (1993) HIV binding to its
receptor creates specific epitopes for CD4/gp120 complex. FEBS J 7 :
1185-1187.
154. Xiang SH, Wang L, Abreu M, et al . (2003) Epitope mapping and
characterization of a novel CD4-induced human monoclonal anti-
body capable of neutralizing primary HIV-1 strains. Virology 315 :
124-134.
155. DeVico AL, Rahman R, Welch J, et al . (1995) Monoclonal antibodies
raised against covalently crosslinked complexes of human immunodefi-
ciency virus type 1 gp120 and CD4 receptor identify a novel complex-
dependent epitope on gp 120. Virology 211 : 583-588.
156. Srivastava I, Ulmer J, Barnett S. (2004) Neutralizing antibody
responses to HIV: role in protective immunity and challenges for vac-
cine design. Expert Opinion in Vaccines.
157. Kwong PD, Wyatt R, Robinson J, et al . (1998) Structure of an HIV
gp120 envelope glycoprotein in complex with the CD4 receptor and a
neutralizing human antibody. Nature 393 : 648-659.
158. Clackson T, Wells JA. (1995) A hot spot of binding energy in a hor-
mone-receptor interface. Science 267 : 383-386.
159. Vita C. (1997) Engineering novel proteins by transfer of active sites to
natural scaffolds. Curr Opin Biotechnol 8 : 429-434.